Watch today

Beyond the Kidneys: Chronic Kidney Disease as a Catalyst for Chronic Disease

Access

12 months

Format

Online Webinar

Duration

2 hours

Presenter

Dr. Michael Osiecki

Chronic Kidney Disease (CKD) is a growing, silent epidemic in Australia and across the globe. More than 22% of adults aged over 35 years are affected, with 11% in advanced stages (3–5). The risk skyrockets with comorbidities as 1 in 4 obese adults and 1 in 5 overweight adults has CKD. Yet, the disease remains vastly underdiagnosed: only 1% of those in early stages and 13% in later stages report a formal diagnosis [1].

Globally, the picture is just as troubling. CKD incidence among young adults (18–34) has doubled in the past decade [2], [3], challenging the outdated notion that kidney disease is confined to older populations.

CKD not only progresses silently, but it also accelerates or contributes to a host of other chronic conditions. With rising rates of obesity, diabetes, and environmental exposures, including post-COVID complications, the need for early detection and prevention is more critical than ever.

CKD is a disease of malnutrition, inflammation, and hormonal and mitochondrial dysfunction with no drug treatments available to slow the progression [4], [5]. That reality places functional medicine practitioners in a prime position to intervene and support people with CKD, offering nutrition-based, systems-oriented support that is often overlooked.

This presentation will make the case for CKD as a central, under-recognised driver of chronic disease, providing tools to detect early cases; and support patients in slowing and preventing their renal function decline. With treatment emphasis on inflammation, gut health and mitochondrial function as well as nutritional guidance on protein, creatine, phosphorous and potassium intakes.

Join Dr. Michael Osiecki for the webinar ‘Beyond the Kidneys: Chronic Kidney Disease as a Catalyst for Chronic Disease.’

Proudly sponsored by

Educational Activities

1

Hours

Reviewing Performance

1

Hours

Measuring Outcomes

0

Hours

MEET YOUR PRESENTER

Dr. Michael Osiecki

PhD, BE(Chemical), BBiotech (Hons) 
Dr. Michael is the Managing Director of Bio Concepts and the second generation of Osiecki biochemists. With scientific prowess and a passion for the industry, Dr. Michael is an industry influencer and thought leader with a vision of making scientific data-driven complementary medicine an integral part of medicine. Dr. Michael is at the forefront of education in nutritional medicine and draws insights from the latest relevant research in complementary medicine, applying these to the clinic and beyond. He has a diverse background which gives him a different perspective and innovative approach. He received his doctorate for research in the field of biological engineering, specialising in isolation and expansion of stem cells in bioreactor systems. Dr. Michael is currently Vice Chairman of the CMA, (Complementary Medicines Australia), the peak industry body representing all stakeholders in Australian complementary medicines and serves as Chair of the Export and Industry Committee and Chair of the Scientific Advisory Working Group. In 2021, Dr. Michael was awarded the CMA Young Achiever of the Year award which recognises innovation, leadership, visionary thinking, and industry contribution amongst the next generation of complementary medicine leaders. 
References
1“Chronic kidney disease,” NHS England Digital. Accessed: Sept. 17, 2025. [Online]. Available: https://digital.nhs.uk/data-and-information/publications/statistical/health-survey-for-england/2022-part-2/kidney-disease
2Australian Institute of Health and Welfare, “Chronic Kidney Disease: Australian Facts,” Aust. Gov., no. Feburary, pp. 1–121, 2023.
3T. Liyanage et al., “Prevalence of chronic kidney disease in Asia: A systematic review and analysis,” BMJ Glob. Health, vol. 7, no. 1, pp. 1–9, 2022, doi: 10.1136/bmjgh-2021-007525.
4C. Zoccali et al., “The systemic nature of CKD,” Nat. Rev. Nephrol., vol. 13, no. 6, pp. 344–358, 2017, doi: 10.1038/nrneph.2017.52.
5M. Ostermann et al., “Micronutrients in critically ill patients with severe acute kidney injury – a prospective study,” Sci. Rep., vol. 10, no. 1, pp. 1–13, 2020, doi: 10.1038/s41598-020-58115-2.